13.07.2015 Views

Social, Cultural and Educational Legacies - ER - NASA

Social, Cultural and Educational Legacies - ER - NASA

Social, Cultural and Educational Legacies - ER - NASA

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

The DeBakey VAD ® functions as a “bridge toheart transplant” by pumping blood throughoutthe body to keep critically ill patients alive until adonor heart is available.These illustrations show a visual comparison ofthe original ventricular assist device (top) <strong>and</strong> theunit after modifications by <strong>NASA</strong> researchers(center <strong>and</strong> bottom). Adding the <strong>NASA</strong>improvements to the MicroMed DeBakey VAD ®eliminated the dangerous backflow of blood byincreasing pressure <strong>and</strong> making flow morecontinuous. The highest pressure around theblade tips are shown in magenta. The blue/greencolors illustrate lower pressures.So, what was it that Dave Saucier <strong>and</strong>the other engineers at JSC thought theyknew that could help make a VAD workbetter, be smaller, <strong>and</strong> help thous<strong>and</strong>sof people seriously ill with heart failure<strong>and</strong> waiting for a transplant? Well,these folks had worked on <strong>and</strong>optimized the turbopumps for theshuttle main engines that happen tohave requirements in common withVAD. The turbopumps needed tomanage high flow rates, minimizeturbulence, <strong>and</strong> eliminate air bubbles.These are also requirements dem<strong>and</strong>edof a VAD by the blood <strong>and</strong> body.In the beginning, VADs had problemssuch as damaging red blood cells <strong>and</strong>having stagnant areas leading to theincreased likelihood of blood clotdevelopment. Red blood cells areessential for carrying oxygen to thetissues of the body. Clots can preventblood from getting to a tissue, resultingin lack of oxygenation <strong>and</strong> buildup oftoxic waste products that lead to tissuedeath. Once engineers resolved theVAD-induced damage to red blood cells<strong>and</strong> clot formation, the device couldenter a new realm of clinical application.In 1996 <strong>and</strong> 1999, engineers from JSC<strong>and</strong> <strong>NASA</strong> Ames Research Center <strong>and</strong>medical colleagues from the BaylorCollege of Medicine were awarded USpatents for a method to reduce pumpingdamage to red blood cells <strong>and</strong> for thedesign of a continuous flow heart pump,respectively. Both of these wereexclusively licensed to MicroMedCardiovascular, Inc. (Houston, Texas)for the further development of the small,implantable DeBakey VAD ® .MicroMed successfully implanted thefirst DeBakey VAD ® in 1998 in Europe<strong>and</strong>, to date, has implanted 440 VADs.MicroMed’s HeartAssist5 ® (the 2009version of the DeBakey VAD ® )weighs less than 100 grams (3.5 oz),is implanted in the chest cavity inthe pericardial space, which reducessurgical complications such asinfections, <strong>and</strong> can operate for as manyas 9 hours on battery power, therebyresulting in greater patient freedom.This device not only acts as a bridgeto transplant, allowing patients to livelonger <strong>and</strong> better lives while waitingfor a donor heart, it is now a destinationtherapy. People are living out theirlives with the implanted device <strong>and</strong>some are even experiencing recovery,which means they can have the deviceexplanted <strong>and</strong> not require a transplant.Making Oxygen Systems SafeHospitals, ambulances, industrialcomplexes, <strong>and</strong> <strong>NASA</strong> all use 100%oxygen <strong>and</strong> all have experienced tragicfires in oxygen-enriched atmospheres.Such fires demonstrated the needfor knowledge related to the use ofmaterials in oxygen-enrichedatmospheres. In fact, on April 18, 1980,an extravehicular mobility unit plannedfor use in the Space Shuttle Programwas destroyed in a dramatic fireduring acceptance testing. In responseto these fire events, <strong>NASA</strong> developeda test method <strong>and</strong> procedures thatsignificantly reduced the danger.The method <strong>and</strong> procedures are nownational <strong>and</strong> international industrialst<strong>and</strong>ards. <strong>NASA</strong> White S<strong>and</strong>s TestFacility (WSTF) also offered courseson oxygen safety to industry <strong>and</strong>government agencies.During the shuttle era, <strong>NASA</strong> madesignificant advances in testing <strong>and</strong>selecting materials for use inhigh-pressure, oxygen-enrichedatmospheres. Early in the shuttle era,engineers became concerned that smallmetal particles could lead to ignitionif the particles were entrained in the277°C (530°F) oxygen that flowedthrough the shuttle’s Main PropulsionSystem gaseous oxygen flow controlvalve. After developing a particleimpact test, <strong>NASA</strong> determined that thestainless-steel valve was vulnerable toparticle impact ignition. Later testingrevealed that a second gaseous oxygenflow control valve, fabricated from analloy with nickel chromium, Inconel ®718, was also vulnerable to particleimpact ignition. Finally, engineersshowed that an alloy with nickel-copper,Monel ® , was invulnerable to ignition byparticle impact <strong>and</strong> consequently wasflown in the Main Propulsion Systemfrom the mid 1980s onward.490Industries <strong>and</strong> Spin-offs

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!